PetVivo Holdings, Inc. (PETV)
USD 0.63
(0.0%)
USD 0.63
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -10.62 Million USD | -21.62% |
| 2023 | -8.73 Million USD | -72.72% |
| 2022 | -5.05 Million USD | -158.12% |
| 2021 | -1.95 Million USD | 2.83% |
| 2020 | -2.01 Million USD | 56.85% |
| 2019 | -4.67 Million USD | -104.47% |
| 2018 | -2.28 Million USD | 86.06% |
| 2017 | -16.38 Million USD | -404.11% |
| 2016 | -3.25 Million USD | -170.51% |
| 2015 | -1.2 Million USD | 96.75% |
| 2014 | -36.97 Million USD | -44769.16% |
| 2013 | -82.4 Thousand USD | 19.53% |
| 2012 | -102.4 Thousand USD | 61.03% |
| 2011 | -262.78 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -10.62 Million USD | -21.62% |
| 2024 Q1 | -2.89 Million USD | -24.24% |
| 2024 Q2 | -2.94 Million USD | -1.75% |
| 2024 Q4 | -2.64 Million USD | -24.19% |
| 2024 Q3 | -2.13 Million USD | 27.53% |
| 2023 Q4 | -2.32 Million USD | -0.44% |
| 2023 Q3 | -2.31 Million USD | -9.4% |
| 2023 Q2 | -2.11 Million USD | -7.81% |
| 2023 Q1 | -1.96 Million USD | -10.64% |
| 2023 FY | -8.73 Million USD | -72.72% |
| 2022 Q2 | -1.1 Million USD | -112.79% |
| 2022 FY | -5.05 Million USD | -158.12% |
| 2022 Q1 | -518.51 Thousand USD | -65.68% |
| 2022 Q3 | -1.65 Million USD | -50.24% |
| 2022 Q4 | -1.77 Million USD | -7.2% |
| 2021 Q2 | -818.56 Thousand USD | -85.17% |
| 2021 Q1 | -442.06 Thousand USD | 14.99% |
| 2021 FY | -1.95 Million USD | 2.83% |
| 2021 Q3 | -385.39 Thousand USD | 52.92% |
| 2021 Q4 | -312.96 Thousand USD | 18.79% |
| 2020 FY | -2.01 Million USD | 56.85% |
| 2020 Q1 | -493.72 Thousand USD | 61.68% |
| 2020 Q2 | -429.61 Thousand USD | 12.98% |
| 2020 Q3 | -572.76 Thousand USD | -33.32% |
| 2020 Q4 | -520.03 Thousand USD | 9.21% |
| 2019 Q1 | 2.09 Million USD | 319.36% |
| 2019 Q4 | -1.28 Million USD | -130.25% |
| 2019 Q3 | -559.61 Thousand USD | 23.09% |
| 2019 Q2 | -727.59 Thousand USD | -134.7% |
| 2019 FY | -4.67 Million USD | -104.47% |
| 2018 FY | -2.28 Million USD | 86.06% |
| 2018 Q4 | -956 Thousand USD | -79.4% |
| 2018 Q3 | -532.89 Thousand USD | -70.2% |
| 2018 Q1 | -483.32 Thousand USD | 28.52% |
| 2018 Q2 | -313.1 Thousand USD | 35.22% |
| 2017 FY | -16.38 Million USD | -404.11% |
| 2017 Q1 | -626.22 Thousand USD | 63.85% |
| 2017 Q4 | -676.18 Thousand USD | -35.63% |
| 2017 Q3 | -498.53 Thousand USD | 96.62% |
| 2017 Q2 | -14.74 Million USD | -2253.81% |
| 2016 Q1 | -1 Million USD | -495.05% |
| 2016 FY | -3.25 Million USD | -170.51% |
| 2016 Q4 | -1.73 Million USD | -438.7% |
| 2016 Q3 | -321.6 Thousand USD | -71.54% |
| 2016 Q2 | -187.47 Thousand USD | 81.43% |
| 2015 Q2 | -105.83 Thousand USD | 88.49% |
| 2015 Q1 | -919.52 Thousand USD | -13.36% |
| 2015 FY | -1.2 Million USD | 96.75% |
| 2015 Q3 | -200.81 Thousand USD | -89.74% |
| 2015 Q4 | -169.66 Thousand USD | 15.51% |
| 2014 Q4 | -811.15 Thousand USD | -954.75% |
| 2014 Q3 | 94.89 Thousand USD | 110.69% |
| 2014 Q2 | -887.76 Thousand USD | -4753.53% |
| 2014 FY | -36.97 Million USD | -44769.16% |
| 2014 Q1 | -18.29 Thousand USD | -19.09% |
| 2013 Q1 | -23.23 Thousand USD | 47.2% |
| 2013 Q2 | -22.72 Thousand USD | 2.18% |
| 2013 Q3 | -21.08 Thousand USD | 7.21% |
| 2013 Q4 | -15.35 Thousand USD | 27.16% |
| 2013 FY | -82.4 Thousand USD | 19.53% |
| 2012 Q3 | -23.65 Thousand USD | -70.68% |
| 2012 Q2 | -13.85 Thousand USD | 33.69% |
| 2012 Q1 | -20.89 Thousand USD | -50.28% |
| 2012 FY | -102.4 Thousand USD | 61.03% |
| 2012 Q4 | -44 Thousand USD | -86.03% |
| 2011 FY | -262.78 Thousand USD | 0.0% |
| 2011 Q1 | -170 Thousand USD | 0.0% |
| 2011 Q2 | -40.9 Thousand USD | 75.94% |
| 2011 Q3 | -35.85 Thousand USD | 12.34% |
| 2011 Q4 | -13.9 Thousand USD | 61.21% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 26.04% |
| Cerus Corporation | -30.05 Million USD | 64.658% |
| OrthoPediatrics Corp. | -25.76 Million USD | 58.778% |
| Talis Biomedical Corporation | -66.81 Million USD | 84.103% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 38.591% |
| Inogen, Inc. | -109.38 Million USD | 90.29% |
| Spectral AI, Inc. | -12.98 Million USD | 18.197% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 83.03% |
| CVRx, Inc. | -43.1 Million USD | 75.358% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -201.058% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 14.537% |
| Orthofix Medical Inc. | -139.11 Million USD | 92.365% |
| Venus Concept Inc. | -28.3 Million USD | 62.481% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 80.341% |
| Bioventus Inc. | -81.72 Million USD | 87.004% |
| BrainsWay Ltd. | -4.92 Million USD | -115.574% |
| Envoy Medical, Inc. | -18.37 Million USD | 42.184% |
| electroCore, Inc. | -18.8 Million USD | 43.519% |
| IceCure Medical Ltd | -15.57 Million USD | 31.81% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 78.092% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 38.491% |
| MaxCyte, Inc. | -48.29 Million USD | 78.009% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 11.158% |
| Nexalin Technology, Inc. | -5.69 Million USD | -86.46% |
| PAVmed Inc | -68.79 Million USD | 84.561% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 81.222% |
| RxSight, Inc. | -50.08 Million USD | 78.793% |
| Sight Sciences, Inc. | -57.27 Million USD | 81.455% |
| SI-BONE, Inc. | -46.93 Million USD | 77.368% |
| TELA Bio, Inc. | -44.07 Million USD | 75.902% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 80.385% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 79.347% |
| LivaNova PLC | -68.49 Million USD | 84.494% |
| 908 Devices Inc. | -42.75 Million USD | 75.159% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 93.874% |
| Nemaura Medical Inc. | -9.59 Million USD | -10.694% |
| NeuroPace, Inc. | -27.17 Million USD | 60.914% |
| LENSAR, Inc. | -12.22 Million USD | 13.146% |
| Apyx Medical Corporation | -17.25 Million USD | 38.459% |
| Cutera, Inc. | -156.23 Million USD | 93.201% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -23.447% |
| BioSig Technologies, Inc. | -28.51 Million USD | 62.748% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 87.881% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 52.68% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 109.524% |
| Axonics, Inc. | -26.05 Million USD | 59.238% |
| Outset Medical, Inc. | -169.77 Million USD | 93.744% |
| IRIDEX Corporation | -10 Million USD | -6.139% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 90.271% |
| IRadimed Corporation | 20.03 Million USD | 153.013% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -28.822% |
| INVO Bioscience, Inc. | -6.76 Million USD | -56.954% |
| Telesis Bio, Inc. | -35.15 Million USD | 69.783% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 174.12% |
| Varex Imaging Corporation | 32.1 Million USD | 133.088% |
| Quipt Home Medical Corp. | 3.91 Million USD | 371.022% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 12.459% |
| Pulmonx Corporation | -61.93 Million USD | 82.851% |
| Dynatronics Corporation | -2.27 Million USD | -367.273% |
| Modular Medical, Inc. | -17.52 Million USD | 39.407% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 27.445% |
| Semler Scientific, Inc. | 22.25 Million USD | 147.723% |
| InMode Ltd. | 195.66 Million USD | 105.428% |
| Bruker Corporation | 436.9 Million USD | 102.431% |
| Cytosorbents Corporation | -31.2 Million USD | 65.967% |
| DexCom, Inc. | 597.7 Million USD | 101.777% |
| Align Technology, Inc. | 643.33 Million USD | 101.651% |
| Viveve Medical, Inc. | -21.55 Million USD | 50.72% |
| ZimVie Inc. | -30.93 Million USD | 65.67% |
| Movano Inc. | -29.69 Million USD | 64.226% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 61.855% |
| Nexalin Technology, Inc. | -5.69 Million USD | -86.46% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -201.058% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 95.446% |
| Profound Medical Corp. | -28.61 Million USD | 62.883% |
| Insulet Corporation | 220 Million USD | 104.828% |
| enVVeno Medical Corporation | -25.23 Million USD | 57.915% |
| Surmodics, Inc. | -5.64 Million USD | -88.155% |
| iCAD, Inc. | -7.68 Million USD | -38.137% |
| Nuwellis, Inc. | -17.63 Million USD | 39.754% |
| Biotricity, Inc. | -8.82 Million USD | -20.311% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 91.514% |
| Aethlon Medical, Inc. | -12.63 Million USD | 15.948% |
| InspireMD, Inc. | -21.14 Million USD | 49.764% |
| PAVmed Inc. | -68.79 Million USD | 84.561% |
| BIOLASE, Inc. | -17.93 Million USD | 40.785% |
| Beyond Air, Inc. | -63 Million USD | 83.142% |
| FONAR Corporation | 16.53 Million USD | 164.234% |
| AxoGen, Inc. | -21.46 Million USD | 50.511% |
| Vivani Medical, Inc. | -26.96 Million USD | 60.611% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 158.873% |
| Inari Medical, Inc. | -14.03 Million USD | 24.306% |
| UFP Technologies, Inc. | 57.66 Million USD | 118.419% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -115.548% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -68.438% |
| Tenon Medical, Inc. | -15.72 Million USD | 32.464% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -42.111% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 75.129% |
| AdaptHealth Corp. | -598.4 Million USD | 98.225% |
| Sintx Technologies, Inc. | -13.35 Million USD | 20.487% |
| NanoVibronix, Inc. | -3.43 Million USD | -209.119% |
| Quanterix Corporation | -49.7 Million USD | 78.63% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 12.459% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -2680.455% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 96.824% |
| TransMedics Group, Inc. | -28.72 Million USD | 63.027% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 55.017% |
| NeuroMetrix, Inc. | -7.15 Million USD | -48.519% |
| Hyperfine, Inc. | -48.11 Million USD | 77.925% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 83.666% |
| Biomerica, Inc. | -6.36 Million USD | -66.819% |
| Bone Biologics Corporation | -9.42 Million USD | -12.654% |
| AVITA Medical, Inc. | -40.4 Million USD | 73.711% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -3.008% |
| Silk Road Medical, Inc | -59.27 Million USD | 82.08% |